ProfileGDS4718 / 225485_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 56% 78% 49% 56% 82% 87% 56% 47% 61% 61% 63% 72% 79% 78% 68% 69% 78% 77% 73% 62% 65% 66% 63% 60% 82% 54% 83% 58% 77% 77% 80% 49% 58% 85% 82% 72% 56% 63% 76% 68% 78% 72% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0479459
GSM549102patient 115, normal, homogenized [OPG study]5.9175656
GSM549104patient 119, normal, homogenized [OPG study]7.7383378
GSM549108patient 138, normal, homogenized [OPG study]5.485249
GSM549119patient 077, normal, homogenized [OPG study]5.85956
GSM549133patient 032, cancer, homogenized [OPG study]8.2505882
GSM549139patient 042, cancer, homogenized [OPG study]8.7333787
GSM549099patient 107, normal, homogenized [OPG study]5.8506656
GSM549109patient 139, normal, homogenized [OPG study]5.3824847
GSM549110patient 046, normal, homogenized [OPG study]6.1659961
GSM549114patient 063, normal, homogenized [OPG study]6.1606661
GSM549122patient 082, normal, homogenized [OPG study]6.3209763
GSM549134patient 033, cancer, homogenized [OPG study]7.0783972
GSM549136patient 036, cancer, homogenized [OPG study]7.8273379
GSM549140patient 044, cancer, homogenized [OPG study]7.7252378
GSM549111patient 047, normal, homogenized [OPG study]6.768668
GSM549113patient 057, normal, homogenized [OPG study]6.7624969
GSM549132patient 031, cancer, homogenized [OPG study]7.6996378
GSM549137patient 038, cancer, homogenized [OPG study]7.6172377
GSM549142patient 047, cancer, homogenized [OPG study]7.0851473
GSM549100patient 110, normal, homogenized [OPG study]6.2718262
GSM549107patient 135, normal, homogenized [OPG study]6.4475965
GSM549115patient 068, normal, homogenized [OPG study]6.5366166
GSM549116patient 072, normal, homogenized [OPG study]6.338463
GSM549120patient 078, normal, homogenized [OPG study]6.1020360
GSM549131patient 030, cancer, homogenized [OPG study]8.2547382
GSM549118patient 074, normal, homogenized [OPG study]5.7748254
GSM549129patient 027, cancer, homogenized [OPG study]8.2332283
GSM549123patient 088, normal, homogenized [OPG study]5.9723758
GSM549124patient 006, cancer, homogenized [OPG study]7.4453677
GSM549126patient 015, cancer, homogenized [OPG study]7.5299177
GSM549128patient 025, cancer, homogenized [OPG study]7.90580
GSM549103patient 117, normal, homogenized [OPG study]5.5200949
GSM549117patient 073, normal, homogenized [OPG study]5.9687558
GSM549138patient 041, cancer, homogenized [OPG study]8.4472285
GSM549141patient 045, cancer, homogenized [OPG study]8.2364382
GSM549130patient 028, cancer, homogenized [OPG study]7.011672
GSM549101patient 111, normal, homogenized [OPG study]5.912956
GSM549105patient 128, normal, homogenized [OPG study]6.3174163
GSM549106patient 134, normal, homogenized [OPG study]7.5814776
GSM549112patient 048, normal, homogenized [OPG study]6.7345968
GSM549125patient 011, cancer, homogenized [OPG study]7.5971278
GSM549127patient 024, cancer, homogenized [OPG study]7.1710272
GSM549135patient 035, cancer, homogenized [OPG study]8.5209885